Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia : a multicenter retrospective study
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany..
BACKGROUND: P. aeruginosa bacteremia is a common and severe infection carrying high mortality in older adults. We aimed to evaluate outcomes of P. aeruginosa bacteremia among old adults (≥ 80 years).
METHODS: We included the 464/2394 (19%) older adults from a retrospective multinational (9 countries, 25 centers) cohort study of individuals hospitalized with P. aeruginosa bacteremia. Bivariate and multivariable logistic regression models were used to evaluate risk factors for 30-day mortality among older adults.
RESULTS: Among 464 adults aged ≥ 80 years, the mean age was 84.61 (SD 3.98) years, and 274 (59%) were men. Compared to younger patients, ≥ 80 years adults had lower Charlson score; were less likely to have nosocomial acquisition; and more likely to have urinary source. Thirty-day mortality was 30%, versus 27% among patients 65-79 years (n = 894) and 25% among patients < 65 years (n = 1036). Multivariate analysis for predictors of mortality among patients ≥ 80 years, demonstrated higher SOFA score (odds ratio [OR] 1.36, 95% confidence interval [CI] 1.23-1.51, p < 0.001), corticosteroid therapy (OR 3.15, 95% CI: 1.24-8.01, p = 0.016) and hospital acquired P. aeruginosa bacteremia (OR 2.30, 95% CI: 1.33-3.98, p = 0.003) as predictors. Appropriate empirical therapy within 24 h, type of definitive anti-pseudomonal drug, and type of regimen (monotherapy or combination) were not associated with 30-day mortality.
CONCLUSIONS: In older adults with P. aeruginosa bacteremia, background conditions, place of acquisition, and disease severity are associated with mortality, rather than the antimicrobial regimen. In this regard, preventive efforts and early diagnosis before organ failure develops might be beneficial for improving outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Infection - 51(2023), 4 vom: 26. Aug., Seite 1003-1012 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 19.07.2023 Date Revised 19.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s15010-022-01973-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35083167X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35083167X | ||
| 003 | DE-627 | ||
| 005 | 20231226045901.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-022-01973-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM35083167X | ||
| 035 | |a (NLM)36571672 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Atamna, Alaa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia |b a multicenter retrospective study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.07.2023 | ||
| 500 | |a Date Revised 19.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. | ||
| 520 | |a BACKGROUND: P. aeruginosa bacteremia is a common and severe infection carrying high mortality in older adults. We aimed to evaluate outcomes of P. aeruginosa bacteremia among old adults (≥ 80 years) | ||
| 520 | |a METHODS: We included the 464/2394 (19%) older adults from a retrospective multinational (9 countries, 25 centers) cohort study of individuals hospitalized with P. aeruginosa bacteremia. Bivariate and multivariable logistic regression models were used to evaluate risk factors for 30-day mortality among older adults | ||
| 520 | |a RESULTS: Among 464 adults aged ≥ 80 years, the mean age was 84.61 (SD 3.98) years, and 274 (59%) were men. Compared to younger patients, ≥ 80 years adults had lower Charlson score; were less likely to have nosocomial acquisition; and more likely to have urinary source. Thirty-day mortality was 30%, versus 27% among patients 65-79 years (n = 894) and 25% among patients < 65 years (n = 1036). Multivariate analysis for predictors of mortality among patients ≥ 80 years, demonstrated higher SOFA score (odds ratio [OR] 1.36, 95% confidence interval [CI] 1.23-1.51, p < 0.001), corticosteroid therapy (OR 3.15, 95% CI: 1.24-8.01, p = 0.016) and hospital acquired P. aeruginosa bacteremia (OR 2.30, 95% CI: 1.33-3.98, p = 0.003) as predictors. Appropriate empirical therapy within 24 h, type of definitive anti-pseudomonal drug, and type of regimen (monotherapy or combination) were not associated with 30-day mortality | ||
| 520 | |a CONCLUSIONS: In older adults with P. aeruginosa bacteremia, background conditions, place of acquisition, and disease severity are associated with mortality, rather than the antimicrobial regimen. In this regard, preventive efforts and early diagnosis before organ failure develops might be beneficial for improving outcomes | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bacteremia | |
| 650 | 4 | |a Octogenarian | |
| 650 | 4 | |a Outcomes | |
| 650 | 4 | |a Pseudomonas | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Margalit, Ili |e verfasserin |4 aut | |
| 700 | 1 | |a Ayada, Gida |e verfasserin |4 aut | |
| 700 | 1 | |a Babich, Tanya |e verfasserin |4 aut | |
| 700 | 1 | |a Naucler, Pontus |e verfasserin |4 aut | |
| 700 | 1 | |a Valik, John Karlsson |e verfasserin |4 aut | |
| 700 | 1 | |a Giske, Christian G |e verfasserin |4 aut | |
| 700 | 1 | |a Benito, Natividad |e verfasserin |4 aut | |
| 700 | 1 | |a Cardona, Ruben |e verfasserin |4 aut | |
| 700 | 1 | |a Rivera, Alba |e verfasserin |4 aut | |
| 700 | 1 | |a Pulcini, Celine |e verfasserin |4 aut | |
| 700 | 1 | |a Fattah, Manal Abdel |e verfasserin |4 aut | |
| 700 | 1 | |a Haquin, Justine |e verfasserin |4 aut | |
| 700 | 1 | |a Macgowan, Alasdair |e verfasserin |4 aut | |
| 700 | 1 | |a Chazan, Bibiana |e verfasserin |4 aut | |
| 700 | 1 | |a Yanovskay, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Ami, Ronen Ben |e verfasserin |4 aut | |
| 700 | 1 | |a Landes, Michal |e verfasserin |4 aut | |
| 700 | 1 | |a Nesher, Lior |e verfasserin |4 aut | |
| 700 | 1 | |a Zaidman-Shimshovitz, Adi |e verfasserin |4 aut | |
| 700 | 1 | |a McCarthy, Kate |e verfasserin |4 aut | |
| 700 | 1 | |a Paterson, David L |e verfasserin |4 aut | |
| 700 | 1 | |a Tacconelli, Evelina |e verfasserin |4 aut | |
| 700 | 1 | |a Buhl, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Mauer, Susanna |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Baño, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a de Cueto, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Oliver, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a de Gopegui, Enrique Ruiz |e verfasserin |4 aut | |
| 700 | 1 | |a Cano, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Machuca, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Gozalo-Marguello, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Martinez, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez-Barbera, Eva M |e verfasserin |4 aut | |
| 700 | 1 | |a Alfaro, Iris Gomez |e verfasserin |4 aut | |
| 700 | 1 | |a Salavert, Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Beovic, Bojana |e verfasserin |4 aut | |
| 700 | 1 | |a Saje, Andreja |e verfasserin |4 aut | |
| 700 | 1 | |a Mueller-Premru, Manica |e verfasserin |4 aut | |
| 700 | 1 | |a Pagani, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Vitrat, Virginie |e verfasserin |4 aut | |
| 700 | 1 | |a Kofteridis, Diamantis |e verfasserin |4 aut | |
| 700 | 1 | |a Zacharioudaki, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Maraki, Sofia |e verfasserin |4 aut | |
| 700 | 1 | |a Weissman, Yulia |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, Mical |e verfasserin |4 aut | |
| 700 | 1 | |a Dickstei, Yaakov |e verfasserin |4 aut | |
| 700 | 1 | |a Yahav, Dafna |e verfasserin |4 aut | |
| 700 | 0 | |a ESCMID study group for infections in elderly (ESGIE) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d 1973 |g 51(2023), 4 vom: 26. Aug., Seite 1003-1012 |w (DE-627)NLM00001740X |x 1439-0973 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2023 |g number:4 |g day:26 |g month:08 |g pages:1003-1012 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15010-022-01973-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2023 |e 4 |b 26 |c 08 |h 1003-1012 | ||